Miseq silver support plan
Ended Purchase Order Awarded Last action
- Contract number
- N6311621P0605
- Awardee
-
Illumina, Inc. UEI KMW3CRWNAAF3
- Awarding agency
-
Bureau of Medicine and Surgery
Department of the Navy, Department of Defense
- Obligated
- $66,285
Award facts
- Opportunity
-
- N4181721QR001 Solicitation number
- Contract value 100% obligated
- $66,284.86 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 811219 Other Electronic and Precision Equipment Repair and Maintenance
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- WPAFB, OH 45433, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$14,633 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $16,460 | |
| Exercise an Option | $15,827 | |
| Exercise an Option | $15,218 | |
| Exercise an Option | $14,633 | |
| Original award | $18,780 |
About this award
The U.S. Navy's Bureau of Medicine and Surgery awarded a purchase order to Illumina, Inc. valued at $66,284.86 for a MiSeq Silver Support Plan, with an ultimate completion date of September 26, 2026. This firm fixed-price contract, awarded on September 27, 2021, reflects a modification to the pay office for the remainder of the service contract and does not utilize a set-aside designation. The work will be performed at Wright-Patterson Air Force Base in Ohio, where the Navy maintains significant research and medical operations facilities.
Illumina, a leading biotechnology company specializing in genetic sequencing and genomic analysis technologies, provides the Navy with critical maintenance and support services for its MiSeq sequencing instrument. The MiSeq platform is a mid-throughput DNA and RNA sequencing system widely used in research, diagnostics, and genomic analysis applications across federal agencies. This support contract ensures continued operational capability of the Navy's genetic sequencing infrastructure, enabling ongoing scientific research and diagnostic capabilities essential to military medical operations and personnel health initiatives.
Quick answers
Who was awarded contract N6311621P0605?
N6311621P0605 was awarded to Illumina, Inc. by Bureau of Medicine and Surgery (Department of the Navy) on September 27, 2021.
How much is contract N6311621P0605 worth?
The government has obligated $66,285 on N6311621P0605.
Was contract N6311621P0605 competed?
The extent of competition for N6311621P0605 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award